Currently out of the existing stock ratings of Mark Massaro, 35 are a HOLD (8.54%), 367 are a BUY (89.51%), 8 are a SELL (1.95%).

Mark Massaro

Work Performance Price Targets & Ratings Chart

Analyst Mark Massaro, currently employed at BTIG, carries an average stock price target met ratio of 55.82% that have a potential upside of 30.43% achieved within 208 days.

Mark Massaro’s has documented 843 price targets and ratings displayed on 46 stocks. The coverage is on Healthcare, Technology, Industrials sectors.

Most recent stock forecast was given on DNA, Ginkgo Bioworks Holdings.

Wall Street Analyst Mark Massaro

Analyst best performing recommendations are on PSNL (PERSONALIS).
The best stock recommendation documented was for PSNL (PERSONALIS) at 8/8/2024. The price target of $5.5 was fulfilled within 8 days with a profit of $2.07 (60.35%) receiving and performance score of 75.44.

Average potential price target upside

of $5583.33 (57.92%) on TTOO (T2 BIOSYSTMS).
of $43.01 (38.9%) on BL (BLACKLINE).
of $35.59 (14.25%) on ILMN (ILLUMINA).

ADPT Adaptive Biotechnologies Corp BLI Berkeley Lights DGX Quest Diagnostics EXAS EXACT Sciences GH Guardant Health GHDX Genomic Health HOLX Hologic HSKA Heska HTGM HTG Molecular Diagnostics IDXX IDEXX Laboratories LH Laboratory of America Holdings NTRA Natera OCX OncoCyte Corp OSUR OraSure Technologies QDEL Quidel QTNT Quotient Ltd RNLX Renalytix AI TTOO T2 Biosystms DNA Ginkgo Bioworks Holdings ILMN Illumina LUCD Lucid Diagnostics NEO NeoGenomics PSNL Personalis TLIS Talis Biomedical Corp VIVO Meridian Bioscience DMTK DermTech HLTH Cue Health LMDX LumiraDx Ltd MXCT MaxCyte SMFR Sema4 Holdings Corp XGN Exagen CDNA Caredx GNMK GenMark Diagnostics AKYA Akoya Biosciences CEMI Chembio Diagnostics CSTL Castle Biosciences MDXH MDxHealth SA ADR BNGO Bionano Genomics CERS Cerus TKNO Alpha Teknova ZTS Zoetis QTRX Quanterix Corp SOPH Sophia Genetics SA BL Blackline CAI CAI International TEM Tempus AI, Common Stock

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

David Westenberg (PIPER SANDLER)

Buy Since 21-Dec-2022

$27.5

$3.22 (13.26%)

$20

1 months 4 days ago
(04-Aug-2026)

14/15 (93.33%)

$2.95 (12.02%)

332

6.76

Tejas Savant (MORGAN STANLEY)

Hold Since 09-Sep-2020

$22

$-2.28 (-9.39%)

$20

1 months 9 days ago
(30-Jul-2026)

12/18 (66.67%)

$-2.18 (-9.02%)

517

9.29

Subbu Nambi (GUGGENHEIM)

Buy Since 30-Sep-2025

$25

$0.72 (2.97%)

$22

1 months 9 days ago
(30-Jul-2026)

5/5 (100%)

$0.82 (3.39%)

6.46

Mark Massaro (BTIG)

Buy Since 07-Oct-2020

$25

$0.72 (2.97%)

$22

1 months 9 days ago
(30-Jul-2026)

16/20 (80%)

$0.82 (3.39%)

188

3.96

Rachel Vatnsdal (JPMORGAN)

Buy Since 03-Aug-2023

$20

$-4.28 (-17.63%)

$10

10 months 2 days ago
(06-Nov-2025)

8/8 (100%)

$4.44 (28.53%)

204

6.27

Show more analysts

Please expand the browser size to see the chart

Which stock is Mark Massaro most bullish on?

Potential upside of $15.38 has been obtained for TEM (TEMPUS AI, COMMON STOCK)

Which stock is Mark Massaro most reserved on?

Potential downside of -$8.18 has been obtained for NTRA (NATERA)

What Year was the first public recommendation made by Mark Massaro?

On 2012